New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies – making them more vulnerable to a severe infection.
FDA Advisory Committee to Review Lykos Therapeutics’ MDMA-Assisted Therapy in Early June – Psychedelic Alpha
Save the date: the FDA will hold an advisory committee meeting to review Lykos Therapeutics’ New Drug Application (NDA) for MDMA-assisted psychotherapy in the treatment of PTSD on
May 7, 2024